Search Results - Holly Edwards
- Showing 1 - 12 results of 12
-
1
-
2
-
3
-
4
Panobinostat synergistically enhances the cytotoxic effects of cisplatin, doxorubicin or etoposide on high-risk neuroblastoma cells. by Guan Wang, Holly Edwards, J Timothy Caldwell, Steven A Buck, William Y Qing, Jeffrey W Taub, Yubin Ge, Zhihong Wang
Published in PLoS ONE (2013-01-01)Get full text
Article -
5
Inhibition of Mcl-1 Synergistically Enhances the Antileukemic Activity of Gilteritinib and MRX-2843 in Preclinical Models of <i>FLT3</i>-Mutated Acute Myeloid Leukemia by Shuangshuang Wu, Holly Edwards, Deying Wang, Shuang Liu, Xinan Qiao, Jenna Carter, Yue Wang, Jeffrey W. Taub, Guan Wang, Yubin Ge
Published in Cells (2022-09-01)Get full text
Article -
6
Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future Prospects by Mohamad Bakkar, Sara Khalil, Komal Bhayekar, Narva Deshwar Kushwaha, Amirreza Samarbakhsh, Sadaf Dorandish, Holly Edwards, Q. Ping Dou, Yubin Ge, Navnath S. Gavande
Published in Biomolecules (2025-02-01)Get full text
Article -
7
Gene Signature of High White Blood Cell Count in B-Precursor Acute Lymphoblastic Leukemia. by Holly Edwards, Mara Rubenstein, Alan A Dombkowski, J Timothy Caldwell, Roland Chu, Ana C Xavier, Ryan Thummel, Melody Neely, Larry H Matherly, Yubin Ge, Jeffrey W Taub
Published in PLoS ONE (2016-01-01)Get full text
Article -
8
A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy. by Ana C Xavier, Holly Edwards, Alan A Dombkowski, Tugce B Balci, Jason N Berman, Graham Dellaire, Chengzhi Xie, Steven A Buck, Larry H Matherly, Yubin Ge, Jeffrey W Taub
Published in PLoS ONE (2011-01-01)Get full text
Article -
9
Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia by Xinyu Li, Yongwei Su, Gerard Madlambayan, Holly Edwards, Lisa Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Jun Ma, Tristan Knight, Guan Wang, Yue Wang, Jay Yang, Jeffrey W. Taub, Hai Lin, Yubin Ge
Published in Haematologica (2019-11-01)Get full text
Article -
10
The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia by Xinyu Li, Yongwei Su, Katie Hege, Gerard Madlambayan, Holly Edwards, Tristan Knight, Lisa Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Jay Yang, Regan Miller, Guan Wang, Lijing Zhao, Yue Wang, Hai Lin, Jeffrey W. Taub, Yubin Ge
Published in Haematologica (2020-03-01)Get full text
Article -
11
Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant FLT3- internal tandem duplication acute myeloid leukemia by Nibal Eid, Jianlei Zhao, Jenna Thibodeau, Holly Edwards, Jing Li, Xun Bao, Lisa Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Steven A. Buck, Jessica B. Back, Paul M. Stemmer, Maurgan Lee, Seongho Kim, Jeffrey W. Taub, Yubin Ge
Published in ASPET Discovery (2025-01-01)Get full text
Article -
12
ONC213: a novel strategy to resensitize resistant AML cells to venetoclax through induction of mitochondrial stress by Jenna L. Carter, Yongwei Su, Eman T. Al-Antary, Jianlei Zhao, Xinan Qiao, Guan Wang, Holly Edwards, Lisa Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Steven A. Buck, Maik Hüttemann, Joshua E. Allen, Varun V. Prabhu, Jay Yang, Jeffrey W. Taub, Yubin Ge
Published in Journal of Experimental & Clinical Cancer Research (2025-01-01)Get full text
Article
